See also this year's filing and all EDGAR filings for this company.
PDF Report 0001388320_2022_Actinium_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001388320, Actinium Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 79,749,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 340,000 |
| 3 | remainder_Assets | 299,000 |
| 4 | LiabilitiesCurrent | 6,840,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 3,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,077,000 |
| 9 | ResearchAndDevelopmentExpense | 18,031,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 1,144,000 |
| 12 | remainder_NetIncome | 190,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 80,388,000 |
| 1 | Liabilities | 6,843,000 |
| 2 | Expenses | 26,108,000 |
| 3 | Revenues | 1,144,000 |
| 4 | StockholdersEquity | 73,545,000 |
| 5 | NetIncome | -24,774,000 |
| 6 | ComprehensiveNetIncome | -24,774,000 |
| 7 | BaseVar | 57,336,500 |
| 8 | EconomicCapitalRatio | 2.33 |
Edgar->Model Mapping
Feature Distribution
Change over Time
